Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Operating activities:
Net income (loss)	$ 7,059	$ (45,123)
Adjustments to reconcile net income (loss) to net cash flows from operating activities:
Depreciation and amortization	23,080	23,174
Amortization of debt discount and deferred financing costs	10,243	9,814
Amortization of lease right-of-use asset	35,885	34,265
Accretion of notes receivable discount and deferred compensation fee	0	(688)
Deferred income taxes	(576)	(3,327)
Impairment of goodwill and intangible assets	0	47,060
Other adjustments	(331)	2,128
Provision for inventory reserve	(6,812)	(4,477)
Stock compensation expense	3,156	5,093
Equity in net (income) loss of unconsolidated affiliates	(2,409)	5,896
Changes in operating assets and liabilities, net of business acquisitions:
Service charges and fees receivable	(2,832)	14,076
Inventory	5,382	12,467
Prepaid expenses, other current assets and other assets	7,908	(3,348)
Accounts payable, accrued expenses and other liabilities	(51,565)	(40,450)
Customer layaway deposits	511	(709)
Income taxes	4,423	514
Net cash provided by operating activities	33,122	56,365
Investing activities:
Loans made	(423,450)	(442,752)
Loans repaid	260,536	321,718
Recovery of pawn loan principal through sale of forfeited collateral	155,595	248,290
Capital expenditures, net	(14,635)	(20,867)
Acquisitions, net of cash acquired	(15,132)	0
Principal collections on notes receivable	0	4,000
Net cash (used in) provided by investing activities	(37,086)	110,389
Financing activities:
Taxes paid related to net share settlement of equity awards	(839)	(1,458)
Payout of deferred consideration	0	(350)
Proceeds from borrowings, net of issuance costs	0	(106)
Payments on assumed debt and other borrowings	(15,363)	(316)
Repurchase of common stock	0	(5,158)
Net cash used in financing activities	(16,202)	(7,388)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	5,076	(6,678)
Net (decrease) increase in cash, cash equivalents and restricted cash	(15,090)	152,688
Cash, cash equivalents and restricted cash at beginning of period	312,553	162,442
Cash, cash equivalents and restricted cash at end of period	297,463	315,130
Supplemental disclosure of cash flow information
Cash and cash equivalents	283,668	311,130
Restricted cash	13,795	4,000
Total cash and cash equivalents and restricted cash	297,463	315,130
Non-cash investing and financing activities:
Pawn loans forfeited and transferred to inventory	145,839	200,160
Transfer of consideration for current period acquisition	1,547	0
Acquisition earn-out contingency	4,608	0
Accrued acquisition consideration held as restricted cash	$ 5,824	$ 0